ACE inhibitors and angiotensin II antagonists in renal transplantation: An analysis of safety and efficacy
- 31 January 2000
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 35 (1) , 58-63
- https://doi.org/10.1016/s0272-6386(00)70302-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- LOSARTAN, AN ANGIOTENSIN-II RECEPTOR ANTAGONIST, REDUCES HEMATOCRITS IN KIDNEY TRANSPLANT RECIPIENTS WITH POSTTRANSPLANT ERYTHROCYTOSISTransplantation, 1997
- Understanding the nature of renal disease progressionKidney International, 1997
- ANTIHYPERTENSIVE DRUG TREATMENT IN CHRONIC RENAL ALLOGRAFT REJECTION IN THE RATTransplantation, 1996
- Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.Journal of Clinical Investigation, 1994
- Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.Journal of Clinical Investigation, 1992
- Fosinopril prevents hyperfiltration and decreases proteinuria in post-transplant hypertensivesKidney International, 1990
- Serum Erythropoietin Levels after Renal TransplantationNew England Journal of Medicine, 1989
- Progression of renal insufficiency: Role of blood pressureKidney International, 1989
- PROTEINURIA FOLLOWING TRANSPLANTATIONTransplantation, 1984
- Captopril-Induced Functional Renal Insufficiency in Patients with Bilateral Renal-Artery Stenoses or Renal-Artery Stenosis in a Solitary KidneyNew England Journal of Medicine, 1983